Hernán Javier Cutuli

Médico Oncólogo - Tumores Urológicos Instituto Angel H. Roffo /
MD. UBA / MSc Biología Molecular UBA / PGDip Biología Molecular UNIVERSIDAD DE LIEJA.

[Toni Choueiri, MD @DrChoueiri]

Argentina 🇦🇷 surreal ……@FIFAWorldCup

[Hernán Javier Cutuli @HernanJCutuli]

https://t.co/9jN9in2IDI

[Hernán Javier Cutuli @HernanJCutuli]

https://t.co/rxUZxTPLw6

[Hernán Javier Cutuli @HernanJCutuli]

https://t.co/2qHp5wFSMU

[FLoscoMD @fedelosco]

🧠 ¿Nefrectomía laparoscópica en tumor renal localizado?

Con MARCO accedí en minutos a:
✅ Evidencia clínica
✅ Guías NCCN
✅ Estudios comparativos
Menos tiempo buscando. Más tiempo decidiendo con respaldo.
🔗 Probalo: https://t.co/ST9ZFC9wmj
ℹ️ Info: https://t.co/z8oG5sAt8J

[Hernán Javier Cutuli @HernanJCutuli]

https://t.co/q002NCSjeZ

[Hernán Javier Cutuli @HernanJCutuli]

https://t.co/TTVmuVOUj6

[Juan OConnor @Juanmaoconnor]

Cómo es el descubrimiento argentino que puede transformar las terapias contra el cáncer en el futuro - Infobae https://t.co/Xw2bfYV8vP

[Hernán Javier Cutuli @HernanJCutuli]

https://t.co/q002NCSjeZ

[Hernán Javier Cutuli @HernanJCutuli]

https://t.co/XDwG5Q6PAT

[Hernán Javier Cutuli @HernanJCutuli]

https://t.co/89B09abK1o

[Gabriel Rabinovich @gabyrabi]

Excited and honored to give a seminar tomorrow at the James Allison Institute, MD Anderson in Houston! Huge thanks to Dr. Pam Sharma and Nobel Laureate Dr. James Allison for the invitation—truly a privilege! People in Houston are wellcome!

[UroToday.com @urotoday]

Evaluating survival in aggressive variant #ProstateCancer patients undergoing PSMA radioligand therapy. Presentation by Moein Moradpour, MD @UCSF. #GU25 written coverage by @chavarriagaj > https://t.co/z0ghvZ4UU5 @ASCO

[Hernán Javier Cutuli @HernanJCutuli]

https://t.co/XDwG5Q6PAT

[Toni Choueiri, MD @DrChoueiri]

3/ Keynote-564: 1st phase 3 trial to demonstrate overall survival benefit for adjuvant treatment in #RCC #Pembrolizumab

⏩38% reduced risk of recurrence/death (HR 0.62)
⏩New SOC for high-risk RCC post-nephrectomy

@NEJM with @ASCO GU 2024

[Andrea Marchioni @AndreaMarchioni]

El primer streaming de #urooncologia
Un placer formar parte de este team! En este capítulo, lo mejor del
2024 👏🏻👏🏻👏🏻

https://t.co/Jya2qLVncY

[Hernán Javier Cutuli @HernanJCutuli]

https://t.co/SOEOO1yv71

[Yüksel Ürün @DrYukselUrun]

Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment, and follow-up!
@myESMO @tompowles1 @AlbigesL @ViktorGruenwald @ravikanesvaran @DrRanaMcKay @g_procopio_ @Silke_Gillessen @crisuarez08 @jteoh_hk @g_develasco @OncoAlert @kidneycan @KidneyCancer
https://t.co/3ST5FzknL6

[Tom Powles @tompowles1]

Couple of questions for #kcrs24
When should immune therapy rechallange at release after adjuvant pembro in clear cell renal cancer occur. @DrChoueiri @montypal @HHammersMD

[Sumanta K. Pal, MD, FASCO @montypal]

Tx @drenriquegrande! I was nervous. @Eminem said "U've only got 1 shot!" & that's true for the @myESMO Prez sesh; didn't want to disappoint @peters_solange @FAndreMD @CharlesSwanton & #ESMO22 audience. I'm no authority on the discussant role but heres my tips 4 trainees; plz add!